PANCREAKARE DIN 02543664
Health Canada record
| Active ingredient(s) | AMYLASE 280000 UNIT; PROTEASE 280000 UNIT; LIPASE 67200 UNIT |
|---|---|
| Dosage form | Powder |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 17-Jan-2024 |
| Current status date | 17-Jan-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Alberta Veterinary Laboratories Ltd. — licence 101939, currently licensed, last inspection rating I (2026-06-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMYLASE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02237093 | DIGESTIVE ENZYMES | ENRICH INTERNATIONAL | Capsule | AMYLASE 4000 UNIT; CELLULASE 1200 UNIT; PROTEASE 15000 UNIT; LIPASE 100 UNIT | Cancelled Post Market |
International API supply for AMYLASE
0 active FDA Drug Master Files.
Request a quote for PANCREAKARE